Advertisement
Canada markets open in 3 hours 28 minutes

  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CAD/USD

    0.7326
    +0.0003 (+0.04%)
     

  • CRUDE OIL

    83.93
    +0.36 (+0.43%)
     

  • Bitcoin CAD

    87,997.04
    +701.74 (+0.80%)
     

  • CMC Crypto 200

    1,391.62
    -4.91 (-0.35%)
     

  • GOLD FUTURES

    2,360.70
    +18.20 (+0.78%)
     

  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • NASDAQ futures

    17,734.00
    +166.50 (+0.95%)
     

  • VOLATILITY

    15.62
    +0.25 (+1.63%)
     

  • FTSE

    8,118.54
    +39.68 (+0.49%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6821
    0.0000 (0.00%)
     

Dynavax Technologies (DVAX) Q1 2023 Earnings Call Transcript

Motley Fool Transcribing, The Motley Fool
·30 min read
Dynavax Technologies (DVAX) Q1 2023 Earnings Call Transcript

Before we begin, I advise you that we will be making forward-looking statements today based on our current expectations and beliefs, including but not limited to, potential market sizes, market segmentation, future expected market share and related growth rates, and related ACIP recommendation impacts on each financial guidance and trends including revenue, profitability, insufficiency of current capitalization, and may results of clinical trial starts and data readouts and for potential future uses of or demand for our CpG 1018 adjuvant. Joining me on the call today are Ryan Spencer, chief executive officer; Donn Casale, chief commercial officer; Rob Janssen, chief medical officer; and Kelly MacDonald, chief financial officer.

Continue reading